14 results
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Equianalgesic Chart - Agents ... and Dosing #Management ... Equianalgesics #Conversion ... #Doses #Dosing ... #Table #PAMI
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
) DOSING: TOOL ... an alternative agent ... #Pharmacology #Conversion ... #Switching #Equivalent ... #Table
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
dose, select an equivalent ... initiating an ARB ... Receptor #Blockers #ARB ... #Conversion #Table ... #Dosing #Pharmacology
Opioid Equianalgesic Equivalence to IV Morphine - Conversion Table

Equipotency estimates are widely variant and often based
Equianalgesic Equivalence ... IV Morphine - Conversion ... Table Equipotency ... estimates are widely ... #Morphine #Table
Angiotensin II Receptor Blocker (ARB) - Comparable Dose Chart 
 - Valsartan (Diovan®) 40 mg daily
Receptor Blocker (ARB ... 20 mg daily #ARB ... #Equivalent #Conversion ... #Dosing #Doseage ... #Table #AngiotensinII
Loop Diuretic Conversion - Dose Equivalents
Bumex (bumetanide) 1 mg PO
Demadex (torsemide) 20 mg PO
Lasix (furosemide) 40
Loop Diuretic Conversion ... - Dose Equivalents ... Loop diuretics are ... they have higher bioavailability ... #Dose #Equivalents
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
phosphate binding agents ... since they are ... not able to effectively ... Note not listed are ... Hyperphosphatemia #Dose #Dosing
CA-Bridge Buprenorphine Hospital Quick Start Algorithm - Management of acute opiate withdrawal 
 - Any prescriber
Hospital Quick Start Algorithm ... If patient is stable ... Buprenorphine Dosing ... sublingual (SL) are ... chronic pain split dosing
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... Switching between oral agents ... of patients who are ... the timing and dosing ... Switching between oral agents
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Any adverse events ... Highest metabolic equivalent ... event, follow ACC algorithm ... ACEi/ARBs - Hold ... Determine if any labs are